Accelerates development of orally inhaled and nasal drug products for pharmaceutical developers by providing automated laboratory testing, advanced data analysis, device selection, and regulatory‑aligned in vitro methods (FDA/ICH). Provides method development, instrument supply and maintenance, and a proprietary by‑design process to optimize drug delivery and shorten time‑to‑market.